Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-02-25 @ 5:44 PM
Study NCT ID:
NCT06435260
Status:
RECRUITING
Last Update Posted:
2025-06-26
First Post:
2024-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Hypofractionated Radiotherapy +Chemotherapy+ Camrelizumab as Neoadjuvant Therapy for Pancreatic Cancer
Sponsor:
Hebei Medical University Fourth Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08-01
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2027-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-24
First Submit QC Date:
None
Study First Post Date:
2024-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-25
Last Update Post Date:
2025-06-26
Last Update Post Date Type:
ACTUAL